Basel, Basel-Stadt, Switzerland The company was established in Europe in Switzerland. The main office of represented Corporate Investor is situated in the Basel.
The typical case for the fund is to invest in rounds with 4 participants. Despite the LifeCare Partners, startups are often financed by VI Partners AG, VINCI CAPITAL, Reference Capital SA. The meaningful sponsors for the fund in investment in the same round are Life Sciences Partners, Omega Funds, Bayern Kapital GmbH. In the next rounds fund is usually obtained by bmp Ventures, Omega Funds, Life Sciences Partners.
The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2016. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. This LifeCare Partners works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2015.
We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Kuros Biosciences, Immunic. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Kupando | $15M | 26 Sep 2022 | - | ||
b-rayZ | $4M | 07 Jul 2022 | Zürich, Zurich, Switzerland | ||
NeoPrediX | $4M | 17 Mar 2021 | Regensburg, Bavaria, Germany | ||
Immunic | $11M | 05 Sep 2017 | San Diego, California, United States | ||
Immunic | $4M | 01 Feb 2017 | San Diego, California, United States | ||
Immunic | $20M | 27 Sep 2016 | San Diego, California, United States | ||
leon nanodrugs | $21M | 27 Jul 2015 | Bavaria |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Kupando | $15M | 26 Sep 2022 | - | ||
b-rayZ | $4M | 07 Jul 2022 | Zürich, Zurich, Switzerland | ||
NeoPrediX | $4M | 17 Mar 2021 | Regensburg, Bavaria, Germany | ||
Immunic | $11M | 05 Sep 2017 | San Diego, California, United States | ||
Immunic | $4M | 01 Feb 2017 | San Diego, California, United States | ||
Immunic | $20M | 27 Sep 2016 | San Diego, California, United States | ||
leon nanodrugs | $21M | 27 Jul 2015 | Bavaria |
